NCT02297438: A Study of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment of Asian Postmenopausal Women With ER+/​HER2- Advanced Breast Cancer (PALOMA-4). This evidence concerns the gene ESR1 and breast carcinoma.